Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study

OBJECTIVE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS(™) study. STUDY DESIGN: A 5-year, global, prospective, multicenter, observational, open-label study conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearce, Ian, Clemens, Andreas, Brent, Michael H., Lu, Lin, Gallego-Pinazo, Roberto, Minnella, Angelo Maria, Creuzot-Garcher, Catherine, Spital, Georg, Sakamoto, Taiji, Dunger-Baldauf, Cornelia, McAllister, Ian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302470/
https://www.ncbi.nlm.nih.gov/pubmed/32555630
http://dx.doi.org/10.1371/journal.pone.0234739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302470/
https://www.ncbi.nlm.nih.gov/pubmed/32555630
http://dx.doi.org/10.1371/journal.pone.0234739

Ejemplares similares